ALPHAMAB ONCOLOGYALPHAMAB ONCOLOGYALPHAMAB ONCOLOGY

ALPHAMAB ONCOLOGY

No trades
See on Supercharts

9966 fundamentals

An in-depth look to ALPHAMAB ONCOLOGY operating, investing, and financing activities

9966 free cash flow for H1 24 is -19.08 M HKD. For 2023, 9966 free cash flow was -212.98 M HKD and operating cash flow was -173 M HKD.

Q1 '18
Q2 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: HKD
Q1 '18
Q2 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM
Free cash flowYoY growth